Principal Short-Term Income Fund R-5 Class
PSIQX
NASDAQ
| Weiss Ratings | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C- | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Principal Funds | |||
| Manager/Tenure (Years) | Michael Goosay (2), Jeff Callahan (1) | |||
| Website | -- | |||
| Fund Information | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Principal Short-Term Income Fund R-5 Class | |||
| Category | Short-Term Bond | |||
| Sub-Category | US Fixed Income | |||
| Prospectus Objective | Corporate Bond - High Quality | |||
| Inception Date | Jul 12, 2010 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 3.72% | |||
| Dividend | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | -- | |||
| Asset Allocation | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 4.25% | |||
| Stock | 0.00% | |||
| U.S. Stock | 0.00% | |||
| Non-U.S. Stock | 0.00% | |||
| Bond | 95.75% | |||
| U.S. Bond | 81.82% | |||
| Non-U.S. Bond | 13.93% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.14% | |||
| 30-Day Total Return | 0.13% | |||
| 60-Day Total Return | 0.34% | |||
| 90-Day Total Return | 0.11% | |||
| Year to Date Total Return | 0.89% | |||
| 1-Year Total Return | 3.86% | |||
| 2-Year Total Return | 9.86% | |||
| 3-Year Total Return | 15.48% | |||
| 5-Year Total Return | 12.20% | |||
| Price | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $12.09 | |||
| 1-Month Low NAV | $12.07 | |||
| 1-Month High NAV | $12.12 | |||
| 52-Week Low NAV | $12.06 | |||
| 52-Week Low NAV (Date) | Jun 06, 2025 | |||
| 52-Week High NAV | $12.21 | |||
| 52-Week High Price (Date) | Feb 27, 2026 | |||
| Beta / Standard Deviation | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.02 | |||
| Standard Deviation | 1.67 | |||
| Balance Sheet | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 3.37B | |||
| Operating Ratios | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.61% | |||
| Turnover Ratio | 42.30% | |||
| Performance | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 4.06% | |||
| Last Bear Market Total Return | -1.46% | |||